Comparative study of the efficacy and safety of topical sertaconazole versus topical terbinafine in the treatment of dermatophytoses in a tertiary care centre

Mrinal Borgohain, Elango P, Darling Chellathai


Background: Dermatophytes are superficial fungal infection termed dermatophytosis, diagnosed by direct microscopy and confirmed with culture and treated with antifungal agents by both topical and systemic therapy. The objective of this study was to compare the efficacy of topical sertaconazole with topical terbinafine applied twice daily in reducing the size and severity of the lesions.

Methods: Two groups of patients, the topical sertaconazole nitrate 2% cream (group 1) and the topical terbinafine hydrochloride 1% cream (group 2) were treated twice daily for 2 weeks and followed after 4 weeks. Skin scrapings were taken to confirm the diagnosis, to assess the efficacy and potency of the study drugs. The statistical analysis was performed using statistical package for Social Sciences. Assessment of the groups was analysed using Chi-square test. Baseline demographic data was analysed using ANOVA.

Results: At the end of first week, sertaconazole group showed significant changes in pruritis (p value 0.045) as compared to terbinafine group (p value <0.05) and no severe symptoms of erythema in both grups. After 2 weeks, resolution of vesicle was seen higher in terbinafine group. But after ‘follow-up phase’, all patients showed absence of vesicles and negative mycological assessment.

Conclusions: Topical sertaconazole nitrate was better in reducing the severity of pruritis and achieving faster mycological cure compared to terbinafine and found to possess additional anti-pruritic and anti-inflammatory action.


Dermatophytosis, Sertaconazole, Terbinafine, Pruritis, Erythema, Vesicles

Full Text:



Calvin OM, Thomas JL. Eczema, psoriasis, cutaneous infections, acne and other common skin disorders. In: Fauci, Braunwald, Kasper, Hauser, Longo, Jameson, Loscalzo, editors. Harrison’s Principles of Internal Medicine. 17th ed, New York:McGraw-Hill; 2008:1:318.

Rippon JW. Superficial infection. In: Chapter 6, In Medical Mycology: The Pathogenic fungi and The Pathogenic Actinomycetes, 3rd edition, W.B. Saunders Co. Philadelphia; 1988:154-159.

Banerjee M, Ghosh AK, Basak S, Das KD, Gangopadhyay DN. Comparative evaluation of effectivity and safety of topical topical amorolfine and clotrimazole in the treatment of tinea corporis. Indian Journal of Dermatology. 2011;56(6):657-62.

Choudhary SV, Bisati S, Singh AL, Koley S. Efficacy and safety of terbinafine hydrochloride 1% cream versus sertaconazole nitrate 2% cream in tinea corporis and tinea cruris: a comparative therapeutic trial. Indian Journal of Dermatology. 2013;58(6):457-60.

Ilkit M. Demirhindi H. Asymptomatic dermatophyte scalp carriage: laboratory diagnosis, epidemiology and management Mycopathologia. 2008;165:61-6.

Jerajani HR, Janaki C, Kumar S, Phiske M. Comparative assessment of sertaconazole, terbinafine, luliconazole cream in dermatophytosis; A Pilot Study. Indian Journal of Dermatology. 2013;58(1):34-38.

Al-Qarqaz F, Al-Aboosi M, Al-Shiyab D, Bataineh A. Using pruritus grading system for measurement of pruritus in patients with diseases associated with itch; J Med J. 2012;46(1):39-44.

Mohanty JC, Mohanty SK, Sahoo RC, Sahoo AS, Praharaj CH. Incidence of dermtophytosis in Orissa. Indian J Med Microbiol. 1998:16:78-80.

Sen SS, Rasul ES. Dermatophytosis in Assam. Indian J Med Microbiol. 2006;24:77-8.

Carrillo-Muñoz AJ, Tur-Tur C, Bornay-Llinares FJ, Arévalo P. Comparative study of the in vitro antifungal activity of bifonazole, naftifine and sertaconazole against yeasts. J Chemother. 1999;11(3):187-90.

Liebel F, Lyte P, Garay M, Babad J, Southall MD. Anti-inflammatory and anti-itch activity of topically applied sertaconazole nitrate. Arch Dermatol Res. 2006;298(4):191-9.

Agut J, Tarrida N, Sacristan A, Ortiz JA. Anti-inflammatory activity of topically applied sertaconazole nitrate. Meth Find Exp Clin Pharmacol 1996;18(4):233-4.

Thaker SJ, Mehta DS, Shah HA, Dave JN, Mundhava SG. A comparative randomized open label study to evaluate efficacy, safety and cost effectiveness between topical 2% sertaconazole and topical 1% butenafine in tinea infections of skin. Indian Journal of Dermatology. 2013;58(6):451-6.